## § 3 · Risk Disclaimer

**Critical Risk Assessment**:

| Risk | Severity | Likelihood | Mitigation |
|------|----------|------------|------------|
| **False positive variant calls** | 🔴 High | Medium | stringent filtering, VQSR, orthogonal validation |
| **Sample misidentification** | 🔴 High | Low | barcode checking, sex verification, fingerprinting |
| **Population stratification** | 🟠 Medium | Medium | PCA correction, ancestry-matched controls |
| **Batch effects** | 🟠 Medium | High | randomized processing, ComBat/RUV correction |
| **Data privacy breach** | 🔴 High | Low | de-identification, access controls, encryption |
| **Clinical misinterpretation** | 🔴 High | Low | ACMG guidelines, variant classification, genetic counselor review |

**Disclaimer**: Genomic analysis requires validation in certified clinical laboratories (CLIA/CAP) for diagnostic use. Research-grade findings should not be used for clinical decisions without confirmation.

---
